nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—head and neck cancer—melanoma	0.163	0.34	CtDrD
Vinblastine—germ cell cancer—melanoma	0.112	0.233	CtDrD
Vinblastine—kidney cancer—melanoma	0.104	0.217	CtDrD
Vinblastine—lung cancer—melanoma	0.101	0.209	CtDrD
Vinblastine—ABCC6—Dactinomycin—melanoma	0.0457	0.13	CbGbCtD
Vinblastine—ABCB1—melanoma	0.035	1	CbGaD
Vinblastine—TUBB8—Docetaxel—melanoma	0.0282	0.0805	CbGbCtD
Vinblastine—TUBB6—Docetaxel—melanoma	0.0282	0.0805	CbGbCtD
Vinblastine—TUBB4A—Docetaxel—melanoma	0.0282	0.0805	CbGbCtD
Vinblastine—TUBB3—Docetaxel—melanoma	0.0282	0.0805	CbGbCtD
Vinblastine—TUBB2B—Docetaxel—melanoma	0.0282	0.0805	CbGbCtD
Vinblastine—TUBB2A—Docetaxel—melanoma	0.0282	0.0805	CbGbCtD
Vinblastine—TUBB—Docetaxel—melanoma	0.0236	0.0673	CbGbCtD
Vinblastine—TUBB4B—Docetaxel—melanoma	0.0236	0.0673	CbGbCtD
Vinblastine—TUBB1—Docetaxel—melanoma	0.0236	0.0673	CbGbCtD
Vinblastine—ABCC1—Vemurafenib—melanoma	0.0203	0.0579	CbGbCtD
Vinblastine—ABCC1—Dactinomycin—melanoma	0.0135	0.0385	CbGbCtD
Vinblastine—ABCC1—Docetaxel—melanoma	0.00696	0.0199	CbGbCtD
Vinblastine—CYP3A4—Temozolomide—melanoma	0.00535	0.0153	CbGbCtD
Vinblastine—ABCC2—Docetaxel—melanoma	0.00515	0.0147	CbGbCtD
Vinblastine—CYP2D6—Vemurafenib—melanoma	0.00461	0.0132	CbGbCtD
Vinblastine—ABCC6—dermis—melanoma	0.00331	0.0987	CbGeAlD
Vinblastine—ABCB1—Dactinomycin—melanoma	0.00325	0.00928	CbGbCtD
Vinblastine—CYP3A4—Vemurafenib—melanoma	0.00293	0.00837	CbGbCtD
Vinblastine—TUBA1A—optic choroid—melanoma	0.00208	0.0622	CbGeAlD
Vinblastine—ABCB1—Docetaxel—melanoma	0.00168	0.00479	CbGbCtD
Vinblastine—JUN—skin epidermis—melanoma	0.00117	0.0348	CbGeAlD
Vinblastine—CYP3A4—Docetaxel—melanoma	0.00101	0.00287	CbGbCtD
Vinblastine—Myelosuppression—Bleomycin—melanoma	0.000928	0.0309	CcSEcCtD
Vinblastine—Myelosuppression—Dactinomycin—melanoma	0.000866	0.0288	CcSEcCtD
Vinblastine—TUBD1—eye—melanoma	0.000862	0.0257	CbGeAlD
Vinblastine—JUN—endothelium—melanoma	0.000845	0.0252	CbGeAlD
Vinblastine—TUBA1A—hair follicle—melanoma	0.000839	0.0251	CbGeAlD
Vinblastine—Myelosuppression—Carmustine—melanoma	0.00081	0.027	CcSEcCtD
Vinblastine—TUBB4B—skin epidermis—melanoma	0.000784	0.0234	CbGeAlD
Vinblastine—Myelosuppression—Temozolomide—melanoma	0.000783	0.0261	CcSEcCtD
Vinblastine—JUN—blood vessel—melanoma	0.00078	0.0233	CbGeAlD
Vinblastine—TUBG1—eye—melanoma	0.000724	0.0216	CbGeAlD
Vinblastine—TUBG1—retina—melanoma	0.000717	0.0214	CbGeAlD
Vinblastine—TUBD1—mammalian vulva—melanoma	0.000684	0.0204	CbGeAlD
Vinblastine—TUBB—hair follicle—melanoma	0.000656	0.0196	CbGeAlD
Vinblastine—Neoplasm—Vemurafenib—melanoma	0.000649	0.0216	CcSEcCtD
Vinblastine—TUBE1—mammalian vulva—melanoma	0.000641	0.0192	CbGeAlD
Vinblastine—TUBG1—skin of body—melanoma	0.00063	0.0188	CbGeAlD
Vinblastine—TUBG1—mammalian vulva—melanoma	0.000574	0.0171	CbGeAlD
Vinblastine—TUBA1A—neck—melanoma	0.000563	0.0168	CbGeAlD
Vinblastine—TUBB4B—hair follicle—melanoma	0.00056	0.0167	CbGeAlD
Vinblastine—JUN—neck—melanoma	0.000558	0.0167	CbGeAlD
Vinblastine—Myelosuppression—Docetaxel—melanoma	0.000521	0.0173	CcSEcCtD
Vinblastine—Extravasation—Bleomycin—melanoma	0.000499	0.0166	CcSEcCtD
Vinblastine—ABCC6—eye—melanoma	0.000495	0.0148	CbGeAlD
Vinblastine—ABCC6—retina—melanoma	0.000491	0.0147	CbGeAlD
Vinblastine—TUBD1—head—melanoma	0.000489	0.0146	CbGeAlD
Vinblastine—TUBB8—head—melanoma	0.000489	0.0146	CbGeAlD
Vinblastine—Extravasation—Dactinomycin—melanoma	0.000465	0.0155	CcSEcCtD
Vinblastine—TUBE1—head—melanoma	0.000459	0.0137	CbGeAlD
Vinblastine—Extravasation—Carmustine—melanoma	0.000435	0.0145	CcSEcCtD
Vinblastine—TUBA1A—eye—melanoma	0.000419	0.0125	CbGeAlD
Vinblastine—TUBA1A—retina—melanoma	0.000415	0.0124	CbGeAlD
Vinblastine—JUN—eye—melanoma	0.000415	0.0124	CbGeAlD
Vinblastine—JUN—retina—melanoma	0.000411	0.0123	CbGeAlD
Vinblastine—TUBG1—head—melanoma	0.000411	0.0123	CbGeAlD
Vinblastine—NR5A1—head—melanoma	0.000401	0.012	CbGeAlD
Vinblastine—ABCC1—hair follicle—melanoma	0.000399	0.0119	CbGeAlD
Vinblastine—Neuropathy peripheral—Vemurafenib—melanoma	0.000394	0.0131	CcSEcCtD
Vinblastine—Phlebitis—Bleomycin—melanoma	0.000367	0.0122	CcSEcCtD
Vinblastine—TUBA1A—skin of body—melanoma	0.000365	0.0109	CbGeAlD
Vinblastine—JUN—skin of body—melanoma	0.000361	0.0108	CbGeAlD
Vinblastine—TUBB4A—eye—melanoma	0.000358	0.0107	CbGeAlD
Vinblastine—TUBB4A—retina—melanoma	0.000355	0.0106	CbGeAlD
Vinblastine—TUBB2B—eye—melanoma	0.000346	0.0103	CbGeAlD
Vinblastine—Ileus—Docetaxel—melanoma	0.000345	0.0115	CcSEcCtD
Vinblastine—Neoplasm—Carmustine—melanoma	0.000343	0.0114	CcSEcCtD
Vinblastine—TUBB2B—retina—melanoma	0.000343	0.0102	CbGeAlD
Vinblastine—TUBD1—lymph node—melanoma	0.000343	0.0102	CbGeAlD
Vinblastine—Phlebitis—Dactinomycin—melanoma	0.000342	0.0114	CcSEcCtD
Vinblastine—TUBB3—head—melanoma	0.000334	0.00997	CbGeAlD
Vinblastine—TUBA1A—mammalian vulva—melanoma	0.000332	0.00993	CbGeAlD
Vinblastine—Neoplasm—Temozolomide—melanoma	0.000332	0.0111	CcSEcCtD
Vinblastine—JUN—mammalian vulva—melanoma	0.000329	0.00983	CbGeAlD
Vinblastine—Neuritis—Docetaxel—melanoma	0.000327	0.0109	CcSEcCtD
Vinblastine—TUBB1—head—melanoma	0.000327	0.00975	CbGeAlD
Vinblastine—TUBB2A—eye—melanoma	0.000326	0.00973	CbGeAlD
Vinblastine—Cerebrovascular accident—Bleomycin—melanoma	0.000322	0.0107	CcSEcCtD
Vinblastine—TUBE1—lymph node—melanoma	0.000321	0.00959	CbGeAlD
Vinblastine—Phlebitis—Carmustine—melanoma	0.00032	0.0107	CcSEcCtD
Vinblastine—Alopecia—Vemurafenib—melanoma	0.000319	0.0106	CcSEcCtD
Vinblastine—TUBB4A—skin of body—melanoma	0.000311	0.0093	CbGeAlD
Vinblastine—Deafness—Temozolomide—melanoma	0.000298	0.00992	CcSEcCtD
Vinblastine—TUBG1—lymph node—melanoma	0.000288	0.00859	CbGeAlD
Vinblastine—TUBB2A—skin of body—melanoma	0.000283	0.00846	CbGeAlD
Vinblastine—ABCC6—head—melanoma	0.000281	0.00839	CbGeAlD
Vinblastine—Extravasation—Docetaxel—melanoma	0.00028	0.00932	CcSEcCtD
Vinblastine—TUBB6—skin of body—melanoma	0.000279	0.00835	CbGeAlD
Vinblastine—TUBB4B—eye—melanoma	0.000279	0.00834	CbGeAlD
Vinblastine—TUBB4B—retina—melanoma	0.000277	0.00826	CbGeAlD
Vinblastine—TUBB2B—mammalian vulva—melanoma	0.000275	0.0082	CbGeAlD
Vinblastine—TUBB—mammalian vulva—melanoma	0.00026	0.00776	CbGeAlD
Vinblastine—Pancytopenia—Bleomycin—melanoma	0.000259	0.00864	CcSEcCtD
Vinblastine—TUBB2A—mammalian vulva—melanoma	0.000258	0.00772	CbGeAlD
Vinblastine—TUBB6—mammalian vulva—melanoma	0.000255	0.00761	CbGeAlD
Vinblastine—Bone pain—Docetaxel—melanoma	0.000255	0.00849	CcSEcCtD
Vinblastine—Voacamine—ABCB1—melanoma	0.000253	0.551	CrCbGaD
Vinblastine—TUBB4B—skin of body—melanoma	0.000243	0.00725	CbGeAlD
Vinblastine—Pancytopenia—Dactinomycin—melanoma	0.000242	0.00806	CcSEcCtD
Vinblastine—Acute coronary syndrome—Bleomycin—melanoma	0.00024	0.008	CcSEcCtD
Vinblastine—Myocardial infarction—Bleomycin—melanoma	0.000239	0.00795	CcSEcCtD
Vinblastine—TUBA1A—head—melanoma	0.000238	0.0071	CbGeAlD
Vinblastine—JUN—head—melanoma	0.000236	0.00703	CbGeAlD
Vinblastine—Pancytopenia—Carmustine—melanoma	0.000226	0.00754	CcSEcCtD
Vinblastine—Decreased appetite—Vemurafenib—melanoma	0.000223	0.00742	CcSEcCtD
Vinblastine—TUBB4B—mammalian vulva—melanoma	0.000222	0.00662	CbGeAlD
Vinblastine—Neoplasm—Docetaxel—melanoma	0.000221	0.00735	CcSEcCtD
Vinblastine—Haemoglobin—Bleomycin—melanoma	0.00022	0.00732	CcSEcCtD
Vinblastine—Constipation—Vemurafenib—melanoma	0.000219	0.0073	CcSEcCtD
Vinblastine—Pancytopenia—Temozolomide—melanoma	0.000219	0.00729	CcSEcCtD
Vinblastine—Haemorrhage—Bleomycin—melanoma	0.000219	0.00728	CcSEcCtD
Vinblastine—Hypoaesthesia—Bleomycin—melanoma	0.000217	0.00724	CcSEcCtD
Vinblastine—Depression—Carmustine—melanoma	0.000212	0.00706	CcSEcCtD
Vinblastine—Agranulocytosis—Dactinomycin—melanoma	0.000212	0.00706	CcSEcCtD
Vinblastine—Neuropathy peripheral—Carmustine—melanoma	0.000208	0.00694	CcSEcCtD
Vinblastine—Phlebitis—Docetaxel—melanoma	0.000206	0.00685	CcSEcCtD
Vinblastine—Depression—Temozolomide—melanoma	0.000205	0.00682	CcSEcCtD
Vinblastine—TUBB4A—head—melanoma	0.000203	0.00607	CbGeAlD
Vinblastine—Pharyngitis—Dactinomycin—melanoma	0.000202	0.00674	CcSEcCtD
Vinblastine—Neuropathy peripheral—Temozolomide—melanoma	0.000201	0.00671	CcSEcCtD
Vinblastine—Deafness—Docetaxel—melanoma	0.000198	0.0066	CcSEcCtD
Vinblastine—TUBB2B—head—melanoma	0.000196	0.00587	CbGeAlD
Vinblastine—Alopecia—Bleomycin—melanoma	0.000193	0.00643	CcSEcCtD
Vinblastine—Haemoglobin—Carmustine—melanoma	0.000192	0.00639	CcSEcCtD
Vinblastine—Haemorrhage—Carmustine—melanoma	0.000191	0.00636	CcSEcCtD
Vinblastine—Hypoaesthesia—Carmustine—melanoma	0.00019	0.00632	CcSEcCtD
Vinblastine—Hypersensitivity—Vemurafenib—melanoma	0.000189	0.00629	CcSEcCtD
Vinblastine—Haemoglobin—Temozolomide—melanoma	0.000185	0.00617	CcSEcCtD
Vinblastine—TUBB2A—head—melanoma	0.000185	0.00552	CbGeAlD
Vinblastine—Haemorrhage—Temozolomide—melanoma	0.000184	0.00614	CcSEcCtD
Vinblastine—Asthenia—Vemurafenib—melanoma	0.000184	0.00613	CcSEcCtD
Vinblastine—Hypoaesthesia—Temozolomide—melanoma	0.000183	0.00611	CcSEcCtD
Vinblastine—Pharyngitis—Temozolomide—melanoma	0.000183	0.0061	CcSEcCtD
Vinblastine—TUBB6—head—melanoma	0.000182	0.00545	CbGeAlD
Vinblastine—Alopecia—Dactinomycin—melanoma	0.00018	0.006	CcSEcCtD
Vinblastine—Ill-defined disorder—Bleomycin—melanoma	0.000177	0.00588	CcSEcCtD
Vinblastine—Anaemia—Bleomycin—melanoma	0.000176	0.00586	CcSEcCtD
Vinblastine—Diarrhoea—Vemurafenib—melanoma	0.000175	0.00584	CcSEcCtD
Vinblastine—Malaise—Bleomycin—melanoma	0.000172	0.00572	CcSEcCtD
Vinblastine—Leukopenia—Bleomycin—melanoma	0.00017	0.00567	CcSEcCtD
Vinblastine—Dizziness—Vemurafenib—melanoma	0.000169	0.00565	CcSEcCtD
Vinblastine—Alopecia—Carmustine—melanoma	0.000169	0.00562	CcSEcCtD
Vinblastine—TUBA1A—lymph node—melanoma	0.000167	0.00497	CbGeAlD
Vinblastine—JUN—lymph node—melanoma	0.000165	0.00492	CbGeAlD
Vinblastine—Ill-defined disorder—Dactinomycin—melanoma	0.000165	0.00548	CcSEcCtD
Vinblastine—Anaemia—Dactinomycin—melanoma	0.000164	0.00546	CcSEcCtD
Vinblastine—Vomiting—Vemurafenib—melanoma	0.000163	0.00543	CcSEcCtD
Vinblastine—Alopecia—Temozolomide—melanoma	0.000163	0.00543	CcSEcCtD
Vinblastine—Headache—Vemurafenib—melanoma	0.000161	0.00535	CcSEcCtD
Vinblastine—Discomfort—Bleomycin—melanoma	0.00016	0.00533	CcSEcCtD
Vinblastine—Malaise—Dactinomycin—melanoma	0.00016	0.00533	CcSEcCtD
Vinblastine—Leukopenia—Dactinomycin—melanoma	0.000159	0.00529	CcSEcCtD
Vinblastine—TUBB4B—head—melanoma	0.000159	0.00473	CbGeAlD
Vinblastine—ABCC1—mammalian vulva—melanoma	0.000158	0.00471	CbGeAlD
Vinblastine—Anaemia—Carmustine—melanoma	0.000153	0.00511	CcSEcCtD
Vinblastine—ABCB1—blood vessel—melanoma	0.000153	0.00456	CbGeAlD
Vinblastine—Nausea—Vemurafenib—melanoma	0.000152	0.00507	CcSEcCtD
Vinblastine—Thrombocytopenia—Bleomycin—melanoma	0.000152	0.00506	CcSEcCtD
Vinblastine—Discomfort—Dactinomycin—melanoma	0.000149	0.00497	CcSEcCtD
Vinblastine—Angina pectoris—Docetaxel—melanoma	0.000149	0.00497	CcSEcCtD
Vinblastine—Ill-defined disorder—Temozolomide—melanoma	0.000149	0.00496	CcSEcCtD
Vinblastine—Leukopenia—Carmustine—melanoma	0.000149	0.00495	CcSEcCtD
Vinblastine—Anaemia—Temozolomide—melanoma	0.000148	0.00494	CcSEcCtD
Vinblastine—Anorexia—Bleomycin—melanoma	0.000148	0.00493	CcSEcCtD
Vinblastine—Pancytopenia—Docetaxel—melanoma	0.000145	0.00485	CcSEcCtD
Vinblastine—Malaise—Temozolomide—melanoma	0.000145	0.00482	CcSEcCtD
Vinblastine—Vertigo—Temozolomide—melanoma	0.000144	0.0048	CcSEcCtD
Vinblastine—Convulsion—Carmustine—melanoma	0.000144	0.00479	CcSEcCtD
Vinblastine—Leukopenia—Temozolomide—melanoma	0.000144	0.00479	CcSEcCtD
Vinblastine—Hypertension—Carmustine—melanoma	0.000143	0.00478	CcSEcCtD
Vinblastine—TUBB4A—lymph node—melanoma	0.000142	0.00425	CbGeAlD
Vinblastine—Thrombocytopenia—Dactinomycin—melanoma	0.000142	0.00472	CcSEcCtD
Vinblastine—Paraesthesia—Bleomycin—melanoma	0.000139	0.00464	CcSEcCtD
Vinblastine—Convulsion—Temozolomide—melanoma	0.000139	0.00463	CcSEcCtD
Vinblastine—Hypertension—Temozolomide—melanoma	0.000139	0.00462	CcSEcCtD
Vinblastine—Anorexia—Dactinomycin—melanoma	0.000138	0.0046	CcSEcCtD
Vinblastine—TUBB2B—lymph node—melanoma	0.000138	0.00411	CbGeAlD
Vinblastine—Discomfort—Temozolomide—melanoma	0.000135	0.0045	CcSEcCtD
Vinblastine—Decreased appetite—Bleomycin—melanoma	0.000135	0.0045	CcSEcCtD
Vinblastine—Acute coronary syndrome—Docetaxel—melanoma	0.000135	0.00449	CcSEcCtD
Vinblastine—Myocardial infarction—Docetaxel—melanoma	0.000134	0.00446	CcSEcCtD
Vinblastine—Neuropathy peripheral—Docetaxel—melanoma	0.000134	0.00446	CcSEcCtD
Vinblastine—Pain—Bleomycin—melanoma	0.000133	0.00442	CcSEcCtD
Vinblastine—Thrombocytopenia—Carmustine—melanoma	0.000133	0.00442	CcSEcCtD
Vinblastine—TUBB—lymph node—melanoma	0.00013	0.00389	CbGeAlD
Vinblastine—TUBB2A—lymph node—melanoma	0.000129	0.00387	CbGeAlD
Vinblastine—Anorexia—Carmustine—melanoma	0.000129	0.0043	CcSEcCtD
Vinblastine—Thrombocytopenia—Temozolomide—melanoma	0.000128	0.00427	CcSEcCtD
Vinblastine—Feeling abnormal—Bleomycin—melanoma	0.000128	0.00426	CcSEcCtD
Vinblastine—TUBB6—lymph node—melanoma	0.000128	0.00381	CbGeAlD
Vinblastine—Agranulocytosis—Docetaxel—melanoma	0.000127	0.00425	CcSEcCtD
Vinblastine—Decreased appetite—Dactinomycin—melanoma	0.000126	0.00419	CcSEcCtD
Vinblastine—Anorexia—Temozolomide—melanoma	0.000125	0.00416	CcSEcCtD
Vinblastine—Pain—Dactinomycin—melanoma	0.000124	0.00413	CcSEcCtD
Vinblastine—Haemoglobin—Docetaxel—melanoma	0.000123	0.00411	CcSEcCtD
Vinblastine—Haemorrhage—Docetaxel—melanoma	0.000123	0.00408	CcSEcCtD
Vinblastine—Hypoaesthesia—Docetaxel—melanoma	0.000122	0.00406	CcSEcCtD
Vinblastine—Paraesthesia—Carmustine—melanoma	0.000122	0.00405	CcSEcCtD
Vinblastine—Pharyngitis—Docetaxel—melanoma	0.000122	0.00405	CcSEcCtD
Vinblastine—Feeling abnormal—Dactinomycin—melanoma	0.000119	0.00398	CcSEcCtD
Vinblastine—Gastrointestinal pain—Dactinomycin—melanoma	0.000118	0.00394	CcSEcCtD
Vinblastine—Decreased appetite—Carmustine—melanoma	0.000118	0.00393	CcSEcCtD
Vinblastine—Paraesthesia—Temozolomide—melanoma	0.000118	0.00392	CcSEcCtD
Vinblastine—Vinorelbine—ABCB1—melanoma	0.000117	0.255	CrCbGaD
Vinblastine—Pain—Carmustine—melanoma	0.000116	0.00386	CcSEcCtD
Vinblastine—Constipation—Carmustine—melanoma	0.000116	0.00386	CcSEcCtD
Vinblastine—Abdominal pain—Dactinomycin—melanoma	0.000114	0.00381	CcSEcCtD
Vinblastine—Hypersensitivity—Bleomycin—melanoma	0.000114	0.00381	CcSEcCtD
Vinblastine—Decreased appetite—Temozolomide—melanoma	0.000114	0.00379	CcSEcCtD
Vinblastine—Pain—Temozolomide—melanoma	0.000112	0.00373	CcSEcCtD
Vinblastine—Constipation—Temozolomide—melanoma	0.000112	0.00373	CcSEcCtD
Vinblastine—Feeling abnormal—Carmustine—melanoma	0.000112	0.00372	CcSEcCtD
Vinblastine—Asthenia—Bleomycin—melanoma	0.000111	0.00371	CcSEcCtD
Vinblastine—TUBB4B—lymph node—melanoma	0.000111	0.00331	CbGeAlD
Vinblastine—Gastrointestinal pain—Carmustine—melanoma	0.000111	0.00369	CcSEcCtD
Vinblastine—Alopecia—Docetaxel—melanoma	0.000108	0.00361	CcSEcCtD
Vinblastine—Feeling abnormal—Temozolomide—melanoma	0.000108	0.0036	CcSEcCtD
Vinblastine—Abdominal pain—Carmustine—melanoma	0.000107	0.00357	CcSEcCtD
Vinblastine—Gastrointestinal pain—Temozolomide—melanoma	0.000107	0.00357	CcSEcCtD
Vinblastine—Hypersensitivity—Dactinomycin—melanoma	0.000107	0.00355	CcSEcCtD
Vinblastine—Asthenia—Dactinomycin—melanoma	0.000104	0.00346	CcSEcCtD
Vinblastine—Abdominal pain—Temozolomide—melanoma	0.000104	0.00345	CcSEcCtD
Vinblastine—Hypersensitivity—Carmustine—melanoma	9.98e-05	0.00333	CcSEcCtD
Vinblastine—Diarrhoea—Dactinomycin—melanoma	9.91e-05	0.0033	CcSEcCtD
Vinblastine—Vomiting—Bleomycin—melanoma	9.87e-05	0.00329	CcSEcCtD
Vinblastine—Anaemia—Docetaxel—melanoma	9.86e-05	0.00329	CcSEcCtD
Vinblastine—Asthenia—Carmustine—melanoma	9.72e-05	0.00324	CcSEcCtD
Vinblastine—Hypersensitivity—Temozolomide—melanoma	9.65e-05	0.00321	CcSEcCtD
Vinblastine—Leukopenia—Docetaxel—melanoma	9.55e-05	0.00318	CcSEcCtD
Vinblastine—Asthenia—Temozolomide—melanoma	9.4e-05	0.00313	CcSEcCtD
Vinblastine—Diarrhoea—Carmustine—melanoma	9.27e-05	0.00309	CcSEcCtD
Vinblastine—Convulsion—Docetaxel—melanoma	9.25e-05	0.00308	CcSEcCtD
Vinblastine—Nausea—Bleomycin—melanoma	9.22e-05	0.00307	CcSEcCtD
Vinblastine—Hypertension—Docetaxel—melanoma	9.21e-05	0.00307	CcSEcCtD
Vinblastine—Vomiting—Dactinomycin—melanoma	9.21e-05	0.00307	CcSEcCtD
Vinblastine—ABCC2—lymph node—melanoma	8.98e-05	0.00268	CbGeAlD
Vinblastine—Dizziness—Carmustine—melanoma	8.96e-05	0.00299	CcSEcCtD
Vinblastine—Diarrhoea—Temozolomide—melanoma	8.96e-05	0.00299	CcSEcCtD
Vinblastine—Vincristine—ABCB1—melanoma	8.89e-05	0.193	CrCbGaD
Vinblastine—Dizziness—Temozolomide—melanoma	8.66e-05	0.00289	CcSEcCtD
Vinblastine—Vomiting—Carmustine—melanoma	8.62e-05	0.00287	CcSEcCtD
Vinblastine—Nausea—Dactinomycin—melanoma	8.6e-05	0.00287	CcSEcCtD
Vinblastine—Thrombocytopenia—Docetaxel—melanoma	8.53e-05	0.00284	CcSEcCtD
Vinblastine—Headache—Carmustine—melanoma	8.49e-05	0.00283	CcSEcCtD
Vinblastine—Vomiting—Temozolomide—melanoma	8.33e-05	0.00277	CcSEcCtD
Vinblastine—Anorexia—Docetaxel—melanoma	8.3e-05	0.00277	CcSEcCtD
Vinblastine—Headache—Temozolomide—melanoma	8.2e-05	0.00273	CcSEcCtD
Vinblastine—Nausea—Carmustine—melanoma	8.05e-05	0.00268	CcSEcCtD
Vinblastine—ABCB1—retina—melanoma	8.05e-05	0.0024	CbGeAlD
Vinblastine—ABCC1—lymph node—melanoma	7.91e-05	0.00236	CbGeAlD
Vinblastine—Paraesthesia—Docetaxel—melanoma	7.82e-05	0.00261	CcSEcCtD
Vinblastine—Nausea—Temozolomide—melanoma	7.78e-05	0.00259	CcSEcCtD
Vinblastine—Decreased appetite—Docetaxel—melanoma	7.57e-05	0.00252	CcSEcCtD
Vinblastine—Pain—Docetaxel—melanoma	7.45e-05	0.00248	CcSEcCtD
Vinblastine—Constipation—Docetaxel—melanoma	7.45e-05	0.00248	CcSEcCtD
Vinblastine—Feeling abnormal—Docetaxel—melanoma	7.18e-05	0.00239	CcSEcCtD
Vinblastine—Gastrointestinal pain—Docetaxel—melanoma	7.12e-05	0.00237	CcSEcCtD
Vinblastine—Abdominal pain—Docetaxel—melanoma	6.89e-05	0.00229	CcSEcCtD
Vinblastine—ABCB1—mammalian vulva—melanoma	6.44e-05	0.00192	CbGeAlD
Vinblastine—Hypersensitivity—Docetaxel—melanoma	6.42e-05	0.00214	CcSEcCtD
Vinblastine—CYP2D6—head—melanoma	6.41e-05	0.00191	CbGeAlD
Vinblastine—Asthenia—Docetaxel—melanoma	6.25e-05	0.00208	CcSEcCtD
Vinblastine—Diarrhoea—Docetaxel—melanoma	5.96e-05	0.00199	CcSEcCtD
Vinblastine—Dizziness—Docetaxel—melanoma	5.76e-05	0.00192	CcSEcCtD
Vinblastine—Vomiting—Docetaxel—melanoma	5.54e-05	0.00184	CcSEcCtD
Vinblastine—Headache—Docetaxel—melanoma	5.46e-05	0.00182	CcSEcCtD
Vinblastine—Nausea—Docetaxel—melanoma	5.17e-05	0.00172	CcSEcCtD
Vinblastine—ABCB1—head—melanoma	4.61e-05	0.00138	CbGeAlD
Vinblastine—ABCB1—lymph node—melanoma	3.23e-05	0.000964	CbGeAlD
Vinblastine—ABCC1—Disease—MAP2K2—melanoma	2.37e-06	3.35e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CUBN—melanoma	2.36e-06	3.35e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.36e-06	3.35e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GPAM—melanoma	2.35e-06	3.32e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CYP1B1—melanoma	2.33e-06	3.3e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CASP8—melanoma	2.32e-06	3.28e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ERBB4—melanoma	2.3e-06	3.26e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—MAPK1—melanoma	2.3e-06	3.26e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—EGFR—melanoma	2.3e-06	3.26e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	2.3e-06	3.26e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDH1—melanoma	2.29e-06	3.24e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CDKN2B—melanoma	2.28e-06	3.24e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SDHD—melanoma	2.28e-06	3.24e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CSPG4—melanoma	2.28e-06	3.24e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—BSG—melanoma	2.28e-06	3.24e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HLA-A—melanoma	2.25e-06	3.19e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TERT—melanoma	2.25e-06	3.19e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—RAC1—melanoma	2.24e-06	3.18e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	2.23e-06	3.17e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.22e-06	3.14e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GPAM—melanoma	2.21e-06	3.13e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CD86—melanoma	2.21e-06	3.13e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ABCB1—melanoma	2.2e-06	3.12e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MAP2K1—melanoma	2.2e-06	3.12e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EDN1—melanoma	2.19e-06	3.1e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	2.19e-06	3.1e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PIK3CD—melanoma	2.19e-06	3.1e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	2.19e-06	3.1e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—KRAS—melanoma	2.17e-06	3.08e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HIF1A—melanoma	2.15e-06	3.05e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—FGF1—melanoma	2.14e-06	3.03e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CSF2—melanoma	2.14e-06	3.03e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CG—melanoma	2.11e-06	3e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—E2F1—melanoma	2.09e-06	2.97e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—FGF2—melanoma	2.09e-06	2.97e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	2.08e-06	2.95e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PDGFRA—melanoma	2.07e-06	2.94e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	2.06e-06	2.93e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ITGB3—melanoma	2.05e-06	2.91e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PRKCA—melanoma	2.05e-06	2.91e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PPARG—melanoma	2.04e-06	2.89e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PRKCA—melanoma	2.03e-06	2.87e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SPP1—melanoma	2.01e-06	2.85e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ERCC2—melanoma	2.01e-06	2.85e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAP2K2—melanoma	2.01e-06	2.84e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PLA2G6—melanoma	1.99e-06	2.83e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—PIK3CA—melanoma	1.99e-06	2.83e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—BCL2—melanoma	1.99e-06	2.82e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IFNG—melanoma	1.97e-06	2.79e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PLCB4—melanoma	1.97e-06	2.79e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MDM2—melanoma	1.96e-06	2.78e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NOS2—melanoma	1.96e-06	2.77e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NOTCH1—melanoma	1.94e-06	2.75e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—ERBB2—melanoma	1.93e-06	2.74e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ABCB1—melanoma	1.92e-06	2.72e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TERT—melanoma	1.91e-06	2.7e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PIK3CB—melanoma	1.9e-06	2.7e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—RAC1—melanoma	1.9e-06	2.7e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CD4—melanoma	1.9e-06	2.7e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CD80—melanoma	1.9e-06	2.69e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.9e-06	2.69e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—APC—melanoma	1.9e-06	2.69e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KIT—melanoma	1.9e-06	2.69e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PLA2G6—melanoma	1.88e-06	2.66e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—EGF—melanoma	1.87e-06	2.66e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CD—melanoma	1.86e-06	2.63e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC6A11—melanoma	1.85e-06	2.62e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.85e-06	2.62e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HRAS—melanoma	1.84e-06	2.62e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.83e-06	2.6e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ALB—melanoma	1.83e-06	2.6e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HIF1A—melanoma	1.82e-06	2.59e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MTAP—melanoma	1.8e-06	2.55e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—VCAN—melanoma	1.79e-06	2.54e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDKN1B—melanoma	1.79e-06	2.53e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—BRAF—melanoma	1.78e-06	2.53e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IL6—melanoma	1.77e-06	2.5e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PRKCA—melanoma	1.76e-06	2.5e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ERCC2—melanoma	1.75e-06	2.48e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL2—melanoma	1.75e-06	2.48e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KDR—melanoma	1.74e-06	2.47e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CTNNB1—melanoma	1.69e-06	2.39e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—VCAN—melanoma	1.69e-06	2.39e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—FN1—melanoma	1.68e-06	2.38e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MAP2K1—melanoma	1.68e-06	2.38e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CD—melanoma	1.67e-06	2.36e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.66e-06	2.36e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—CDKN1A—melanoma	1.65e-06	2.34e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PTEN—melanoma	1.65e-06	2.33e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NOTCH1—melanoma	1.64e-06	2.33e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—NFKB1—melanoma	1.64e-06	2.32e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—AKT1—melanoma	1.63e-06	2.31e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CB—melanoma	1.62e-06	2.3e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CD80—melanoma	1.61e-06	2.28e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—APC—melanoma	1.61e-06	2.28e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CG—melanoma	1.61e-06	2.28e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KIT—melanoma	1.61e-06	2.28e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PHGDH—melanoma	1.6e-06	2.28e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—LUM—melanoma	1.6e-06	2.28e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTGS2—melanoma	1.6e-06	2.27e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—FGF2—melanoma	1.6e-06	2.26e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EGF—melanoma	1.59e-06	2.25e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CG—melanoma	1.59e-06	2.25e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HPSE—melanoma	1.57e-06	2.23e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.55e-06	2.2e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CUBN—melanoma	1.54e-06	2.19e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PPARG—melanoma	1.53e-06	2.17e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP17A1—melanoma	1.51e-06	2.14e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—BRAF—melanoma	1.51e-06	2.14e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MDM2—melanoma	1.49e-06	2.12e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SDHD—melanoma	1.49e-06	2.12e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CSPG4—melanoma	1.49e-06	2.12e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—BSG—melanoma	1.49e-06	2.12e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—STAT3—melanoma	1.47e-06	2.09e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IGF1—melanoma	1.47e-06	2.09e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—ERBB2—melanoma	1.47e-06	2.09e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—NRAS—melanoma	1.47e-06	2.08e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CB—melanoma	1.45e-06	2.06e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CD4—melanoma	1.45e-06	2.06e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GPAM—melanoma	1.44e-06	2.05e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTGS2—melanoma	1.44e-06	2.04e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GNA11—melanoma	1.43e-06	2.02e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP17A1—melanoma	1.42e-06	2.02e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAP2K1—melanoma	1.42e-06	2.02e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CD—melanoma	1.41e-06	2e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MAPK3—melanoma	1.41e-06	1.99e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.4e-06	1.98e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTEN—melanoma	1.4e-06	1.98e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—FASN—melanoma	1.4e-06	1.98e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CD—melanoma	1.4e-06	1.98e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CG—melanoma	1.38e-06	1.96e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ALB—melanoma	1.38e-06	1.95e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SLC5A5—melanoma	1.37e-06	1.95e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CDKN1B—melanoma	1.36e-06	1.93e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—FGF2—melanoma	1.35e-06	1.92e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GNA11—melanoma	1.34e-06	1.91e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MAPK1—melanoma	1.34e-06	1.9e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—EGFR—melanoma	1.34e-06	1.9e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PPARG—melanoma	1.33e-06	1.89e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GNAQ—melanoma	1.33e-06	1.88e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CD44—melanoma	1.33e-06	1.88e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—FASN—melanoma	1.32e-06	1.87e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SLC5A5—melanoma	1.29e-06	1.84e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CTNNB1—melanoma	1.29e-06	1.83e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP1B1—melanoma	1.27e-06	1.8e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MDM2—melanoma	1.27e-06	1.79e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—KRAS—melanoma	1.26e-06	1.79e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CDKN1A—melanoma	1.26e-06	1.78e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTEN—melanoma	1.25e-06	1.78e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GNAQ—melanoma	1.25e-06	1.77e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CD44—melanoma	1.25e-06	1.77e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ERBB2—melanoma	1.25e-06	1.77e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CB—melanoma	1.23e-06	1.75e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PLA2G6—melanoma	1.23e-06	1.74e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CB—melanoma	1.22e-06	1.72e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CD—melanoma	1.22e-06	1.72e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTGS2—melanoma	1.21e-06	1.71e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ALB—melanoma	1.2e-06	1.7e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP1B1—melanoma	1.2e-06	1.7e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CXCL8—melanoma	1.18e-06	1.68e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—PIK3CA—melanoma	1.16e-06	1.65e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CDKN1B—melanoma	1.16e-06	1.64e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CASP3—melanoma	1.13e-06	1.61e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL2—melanoma	1.13e-06	1.6e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—STAT3—melanoma	1.12e-06	1.59e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NRAS—melanoma	1.12e-06	1.59e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—VCAN—melanoma	1.1e-06	1.56e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCND1—melanoma	1.1e-06	1.56e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CTNNB1—melanoma	1.09e-06	1.55e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—HRAS—melanoma	1.07e-06	1.52e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MAPK3—melanoma	1.07e-06	1.52e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MMP9—melanoma	1.07e-06	1.52e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CDKN1A—melanoma	1.07e-06	1.51e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTEN—melanoma	1.06e-06	1.51e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NFKB1—melanoma	1.06e-06	1.5e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CB—melanoma	1.06e-06	1.5e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTEN—melanoma	1.05e-06	1.49e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTGS2—melanoma	1.05e-06	1.49e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MYC—melanoma	1.04e-06	1.48e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL6—melanoma	1.03e-06	1.46e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MAPK1—melanoma	1.02e-06	1.45e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—EGFR—melanoma	1.02e-06	1.45e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ABCB1—melanoma	9.87e-07	1.4e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CA—melanoma	9.87e-07	1.4e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PRKCA—melanoma	9.64e-07	1.37e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KRAS—melanoma	9.64e-07	1.37e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—VEGFA—melanoma	9.61e-07	1.36e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ERCC2—melanoma	9.56e-07	1.36e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—STAT3—melanoma	9.52e-07	1.35e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NRAS—melanoma	9.49e-07	1.35e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—AKT1—melanoma	9.49e-07	1.34e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP17A1—melanoma	9.31e-07	1.32e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTEN—melanoma	9.15e-07	1.3e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAPK3—melanoma	9.09e-07	1.29e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PRKCA—melanoma	9.08e-07	1.29e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ERCC2—melanoma	9.01e-07	1.28e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3CA—melanoma	8.85e-07	1.26e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MYC—melanoma	8.84e-07	1.25e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GNA11—melanoma	8.79e-07	1.25e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAPK1—melanoma	8.65e-07	1.23e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EGFR—melanoma	8.65e-07	1.23e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—FASN—melanoma	8.6e-07	1.22e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC5A5—melanoma	8.46e-07	1.2e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HRAS—melanoma	8.19e-07	1.16e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CD44—melanoma	8.17e-07	1.16e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GNAQ—melanoma	8.17e-07	1.16e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KRAS—melanoma	8.17e-07	1.16e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—AKT1—melanoma	8.06e-07	1.14e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IL6—melanoma	7.84e-07	1.11e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP1B1—melanoma	7.84e-07	1.11e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CG—melanoma	7.55e-07	1.07e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CA—melanoma	7.51e-07	1.06e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CA—melanoma	7.41e-07	1.05e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PPARG—melanoma	7.29e-07	1.03e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TP53—melanoma	7.26e-07	1.03e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—AKT1—melanoma	7.23e-07	1.03e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CG—melanoma	7.12e-07	1.01e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HRAS—melanoma	6.95e-07	9.85e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPARG—melanoma	6.87e-07	9.74e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL6—melanoma	6.65e-07	9.43e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CD—melanoma	6.64e-07	9.41e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ALB—melanoma	6.55e-07	9.29e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CA—melanoma	6.46e-07	9.15e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ABCB1—melanoma	6.45e-07	9.15e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CD—melanoma	6.26e-07	8.87e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ALB—melanoma	6.18e-07	8.75e-06	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—AKT1—melanoma	6.13e-07	8.7e-06	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—AKT1—melanoma	6.06e-07	8.59e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PRKCA—melanoma	5.94e-07	8.42e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ERCC2—melanoma	5.89e-07	8.35e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CB—melanoma	5.79e-07	8.2e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTGS2—melanoma	5.73e-07	8.13e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CB—melanoma	5.45e-07	7.73e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTGS2—melanoma	5.4e-07	7.66e-06	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—AKT1—melanoma	5.27e-07	7.48e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTEN—melanoma	5e-07	7.09e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTEN—melanoma	4.71e-07	6.68e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CG—melanoma	4.65e-07	6.6e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPARG—melanoma	4.49e-07	6.37e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CD—melanoma	4.09e-07	5.8e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ALB—melanoma	4.04e-07	5.72e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CB—melanoma	3.56e-07	5.05e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTGS2—melanoma	3.53e-07	5.01e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CA—melanoma	3.53e-07	5e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CA—melanoma	3.32e-07	4.71e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTEN—melanoma	3.08e-07	4.37e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—AKT1—melanoma	2.88e-07	4.09e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—AKT1—melanoma	2.72e-07	3.85e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CA—melanoma	2.17e-07	3.08e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—AKT1—melanoma	1.78e-07	2.52e-06	CbGpPWpGaD
